Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02497469
Brief Title: An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

First Submitted : July 10, 2015
First Submitted that Met QC Criteria : July 10, 2015
First Posted : July 14, 2015 (Estimate)

Results First Submitted : September 17, 2019
Results First Submitted that Met QC Criteria : September 17, 2019
Results First Posted : October 10, 2019

Last Update Submitted that Met QC Criteria : September 17, 2019
Last Update Posted : October 10, 2019